Natalie L. Rasgon

Natalie L. Rasgon

Psychiatrist

Bio:   Dr. Rasgon is a Professor in the Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology in the Stanford School of Medicine. Dr. Rasgon has been involved in longitudinal placebo-controlled neuroendocrine studies for over two decades, and she has been involved in neuroendocrine and brain imaging studies of estrogen effects on depressed menopausal women for over 10 years. In addition to her duties as a Professor of Psychiatry and Obstetrics & Gynecology, Dr. Rasgon is also the Director of the Stanford Center for Neuroscience in Women’s Health and Associate Dean of Academic Affairs for the School of Medicine. She has an extensive history of teaching and mentoring, and many of her trainees have secured independent faculty positions in academia.

Outpatient Psychiatry Clinic

Professional Education

  • Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1998)
  • Fellowship: UCLA Medical Center (1996) CA
  • Residency: Cedars-Sinai Medical Center (1995) CA
  • Internship: Harbor-UCLA Medical Center (1993) CA
  • Medical Education: Odessa Medical Institute (1980) Russia
  • PhD, Academy of Medical Sciences, Pathological Physiology (1988)
  • PhD, Academy of Medical Sciences, Obstetrics & Gynecology (1988)
  • MD, Odessa Medical Institute, Diploma with Highest Honors (1980)

Honors & Awards

  • Diploma with Highest Honors, Odessa Medical Institute (1980)
  • Elected to Database, Best Doctors in America (November 2012)
  • Fellowship, Stanford Clayman Institute for Gender Research (2011)
  • First Prize, Student Research Work, Soviet Union Scientific Student Competition (1978)
  • International Scientist of the Year, International Biographical Centre of Cambridge, England (2002)
  • Leo G. Rigler, M.D. Award for Academic Achievement, Cedars-Sinai Medical Center (1995)
  • Lila A. Wallis Award, American Medical Women's Association (2010)

Administrative Appointments

  • Administrative Panel on Human Subjects in Medical Research, Stanford University (2004 - 2009)
  • Advisory Board on Women?s Health, Stanford Unviversity (2004 - Present)
  • Alternate Senator, Stanford School of Medicine (2004 - 2006)
  • Associate Dean, Office of Academic Affairs (2012 - 2013)
  • Chair of the SOM Senate, Stanford School of Medicine (2009 - 2012)
  • Chair, Search Committee for the Elizabeth Blackwell Award, UCLA School of Medicine (1999 - 2003)
  • Chair, Women?s Wellness Seminars Program, Stanford University (2003 - Present)
  • Co-Chair, Faculty Women?s Forum, Stanford University (2004 - Present)
  • Director, Stanford Center for Neuroscience in Women's Health (2002 - Present)
  • Director, Center for Neuroscience in Women?s Health, Stanford University (2007 - Present)
  • Director, Faculty Mentoring Program, Department of Psychiatry, Stanford University (2009 - Present)
  • Director, Stanford Women?s Health Component, Ph.D. Program, Pacific Graduate School of Psychology (2009 - Present)
  • International Medical Graduates Committee, Southern California Psychiatric Society (1993 - 2001)
  • Medical School Admissions Panel, Stanford University (2003 - 2005)
  • Member, Scholar Universe Neuroscience (2004 - Present)
  • Member, Appointments and promotions committee SOM (2009 - 2012)
  • Search Committee for the Norman Cousins Psychoneuroimmunology Chair, UCLA School of Medicine (1998 - 1998)
  • UCLA Liver Transplant Committee, UCLA School of Medicine (1997 - 2002)
  • Women's Cardiovascular Health Committee, Stanford Cardiovascular Institute (2004 - Present)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.